Highlight Therapeutics Competitors and Similar CompaniesClear all
Highlight Therapeutics's competitors and similar companies include Biomea Fusion, CytoMed Therapeutics and Nexomics Biosciences.
 Highlight Therapeutics Highlight Therapeutics (formerly Bioncotech) is a clinical-stage immune-oncology company. |  Biomea Fusion Biomea Fusion is a biopharmaceutical company focused on the discovery, development, and commercialization of irreversible small molecules to treat patients with genetically defined cancers. |  CytoMed Therapeutics CytoMed Therapeutics is a company that focuses on translating its technologies into gamma delta (γδ) T cell- and natural killer (NK) cell-based immunotherapeutics for the treatment of cancers. |  Nexomics Biosciences Nexomics Biosciences is a contract research organization offering gene-to‑structure services to the biopharmaceutical community. | |
Founding Date | Founding Date 2010 | Founding Date 2017 | Founding Date 2018 | Founding Date 2007 |
Type | Type Private | Type Public | Type Private | Type Private |
Tags | ||||
Locations | Locations Paterna, Valencia, ES HQ | Locations Redwood City, US HQ | Locations Singapore, SG HQ Masai, MY | Locations Rocky Hill, US HQ Mansfield, US |
Employees | Employees 16 | Employees 1240% decrease | Employees 24 | Employees 1220% increase |
For sources of this data, please see the company profile
View Company Profiles
Biomea Fusion
HQ
Redwood City, US
Employees
12↓ 40% decrease
Biomea Fusion is a biopharmaceutical company focused on the discovery, development, and commercialization of irreversible small molecules to treat patients with genetically defined cancers.
View companyCytoMed Therapeutics
HQ
Singapore, SG
Employees
24
CytoMed Therapeutics is a company that focuses on translating its technologies into gamma delta (γδ) T cell- and natural killer (NK) cell-based immunotherapeutics for the treatment of cancers.
View companyNexomics Biosciences
HQ
Rocky Hill, US
Employees
12↑ 20% increase
Nexomics Biosciences is a contract research organization offering gene-to‑structure services to the biopharmaceutical community.
View company